Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 W Harrison St
Chicago, IL 60607Phone+1 800-226-2371Fax+1 206-568-7043
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
Temple University HospitalResidency, Internal Medicine, 2008 - 2010
Yale-New Haven Medical CenterInternship, Internal Medicine, 2003 - 2004
Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
IL State Medical License 2024 - 2026
NJ State Medical License 2024 - 2025
CT State Medical License 2024 - 2024
WA State Medical License 2022 - 2024
PA State Medical License 2008 - 2022
DC State Medical License 2011 - 2014
MD State Medical License 2013 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
- Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance Start of enrollment: 2018 May 15
Publications & Presentations
PubMed
- 2 citationsIntegrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North Am...Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart
Journal of Hematology & Oncology. 2023-12-16 - 15 citationsTargeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Pha...Elisabeth A Lasater, Dhara N Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett
American Journal of Hematology. 2023-03-01 - 48 citationsNCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami
Journal of the National Comprehensive Cancer Network. 2022-06-01
Abstracts/Posters
- The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)Nadia Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell LymphomasNadia Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...Nadia Khan, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
Press Mentions
'Possibility of Cure' for Some Patients with CLLSeptember 10th, 2019
Will Obinutuzumab Replace Rituximab for CLL Combination Treatment?September 26th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
